Should I buy or sell Aspira Women's Health stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aspira Women's Health in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AWH shares. View AWH analyst ratings or view top-rated stocks .

What is Aspira Women's Health's stock price target for 2024?

2 Wall Street analysts have issued 1 year target prices for Aspira Women's Health's shares. Their AWH share price targets range from $3.30 to $5.60. On average, they anticipate the company's share price to reach $4.45 in the next twelve months. This suggests a possible upside of 26.1% from the stock's current price. View analysts price targets for AWH or view top-rated stocks among Wall Street analysts .

How have AWH shares performed in 2024?

Aspira Women's Health's stock was trading at $4.08 at the beginning of 2024. Since then, AWH shares have decreased by 13.5% and is now trading at $3.53. View the best growth stocks for 2024 here .

When is Aspira Women's Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our AWH earnings forecast .

How were Aspira Women's Health's earnings last quarter?

Aspira Women's Health Inc. (NASDAQ:AWH) posted its earnings results on Wednesday, November, 10th. The company reported ($1.35) EPS for the quarter, missing analysts' consensus estimates of ($1.05) by $0.30. The firm earned $1.67 million during the quarter, compared to the consensus estimate of $1.50 million. Aspira Women's Health had a negative trailing twelve-month return on equity of 1,099.32% and a negative net margin of 176.74%. During the same quarter in the prior year, the company posted ($0.60) earnings per share.

When did Aspira Women's Health's stock split?

Shares of Aspira Women's Health reverse split on Friday, May 12th 2023. The 1-15 reverse split was announced on Friday, May 12th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What is Scott A. Carmilani's approval rating as Aspira Women's Health's CEO?

33 employees have rated Aspira Women's Health Chief Executive Officer Scott A. Carmilani on Glassdoor.com . Scott A. Carmilani has an approval rating of 92% among the company's employees. This puts Scott A. Carmilani in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 97.0% of employees surveyed would recommend working at Aspira Women's Health to a friend.

What other stocks do shareholders of Aspira Women's Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aspira Women's Health investors own include AcelRx Pharmaceuticals (ACRX) , Aptinyx (APTX) , Axcella Health (AXLA) , Aytu BioPharma (AYTU) , Calithera Biosciences (CALA) , Cidara Therapeutics (CDTX) , Catalyst Pharmaceuticals (CPRX) , DURECT (DRRX) , Geron (GERN) and

How do I buy shares of Aspira Women's Health?

Shares of AWH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:AWH

Aspira Women's Health (AWH) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free AWH Stock Alerts

$3.53

+0.04 (+1.15%)

(As of 04/18/2024 ET)

Compare

Today's Range: $3.40
▼
$3.57
50-Day Range: $2.64
▼
$4.96
52-Week Range: $2.31
▼
$6.75

Volume: 7,831 shs
Average Volume: 31,847 shs
Market Capitalization: $43.56 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $4.45

Get Aspira Women's Health alerts:

Aspira Women's Health MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 26.1% Upside
$4.45 Price Target
Short Interest: Healthy
2.14% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($1.24) to ($0.86) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.99 out of 5 stars

Medical Sector

795th out of 918 stocks

Diagnostics & Research Industry

2nd out of 4 stocks

3.3

Analyst's Opinion

Consensus Rating
Aspira Women's Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Amount of Analyst Coverage
Aspira Women's Health has only been the subject of 1 research reports in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
2.14% of the float of Aspira Women's Health has been sold short.
Short Interest Ratio / Days to Cover
Aspira Women's Health has a short interest ratio ("days to cover") of 4.
Change versus previous month
Short interest in Aspira Women's Health has recently decreased by 12.97%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Aspira Women's Health does not currently pay a dividend.
Dividend Growth
Aspira Women's Health does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for AWH.

0.0

News and Social Media Coverage

Search Interest
Only 1 people have searched for AWH on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Aspira Women's Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Aspira Women's Health insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 4.30% of the stock of Aspira Women's Health is held by insiders.
Percentage Held by Institutions
Only 12.19% of the stock of Aspira Women's Health is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Aspira Women's Health are expected to grow in the coming year, from ($1.24) to ($0.86) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Aspira Women's Health is -0.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Aspira Women's Health is -0.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Aspira Women's Health Stock (NASDAQ:AWH)

Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company's products include Ova1, a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker reflex test; and Ova1Plus, a reflex offering. Its product pipeline includes OvaWatch, a non-invasive blood-based risk assessment test to determine ovarian cancer risk for patients with an adnexal mass; and Endocheck, an in-development non-invasive blood test designed as an aid in the identification of endometriosis for patients with suspected endometriosis earlier in their prognosis journey. In addition, the company operates Aspira Synergy, a testing platform and cloud service; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. The company serves physicians, physician office laboratories, and national and regional laboratories. The company distributes its products through its national sales force, its platform Aspira Synergy, and a marketing and distribution agreement with BioReference Health, LLC. It has a research agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is based in Austin, Texas.

AWH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AWH Stock News Headlines

April 11, 2024 | americanbankingnews.com

Cantor Fitzgerald Reiterates Neutral Rating for Aspira Women's Health (NASDAQ:AWH)

April 9, 2024 | globenewswire.com

Aspira Women's Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 5, 2024 | msn.com

Aspira Women's Health files to sell 1.57M shares for holders

April 3, 2024 | benzinga.com

Aspira Womens Health Stock (NASDAQ:AWH), Analyst Ratings, Price Targets, Predictions

April 1, 2024 | msn.com

Aspira Women’s Health Inc. (NASDAQ:AWH) Q4 2023 Earnings Call Transcript

March 30, 2024 | seekingalpha.com

Aspira Women's Health Inc. (AWH) Q4 2023 Earnings Call Transcript

March 28, 2024 | msn.com

Aspira Women’s Health GAAP EPS of -$0.30 beats by $0.15, revenue of $2.13M misses by $0.42M

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 28, 2024 | finanznachrichten.de

Aspira Women's Health Inc.: Aspira Women's Health Reports Fourth Quarter and Full Year 2023 Financial Results

March 28, 2024 | finance.yahoo.com

Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results

March 28, 2024 | globenewswire.com

Aspira Women's Health Reports Fourth Quarter and Full Year 2023 Financial Results

March 27, 2024 | stockhouse.com

Aspira Women's Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and Call

March 27, 2024 | benzinga.com

A Preview Of Aspira Womens Health's Earnings

March 25, 2024 | finance.yahoo.com

Aspira Women’s Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and Call

March 21, 2024 | finance.yahoo.com

Aspira Women’s Health to Present at the MedInvest Biotech & Pharma Investor Conference

March 21, 2024 | globenewswire.com

Aspira Women's Health to Present at the MedInvest Biotech & Pharma Investor Conference

March 20, 2024 | stockhouse.com

Aspira Women's Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as President

March 18, 2024 | finance.yahoo.com

Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as President

March 11, 2024 | finance.yahoo.com

Aspira Women’s Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024

March 11, 2024 | globenewswire.com

Aspira Women's Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024

February 22, 2024 | finance.yahoo.com

Aspira Women’s Health to Present at The Cancer Advocacy Group of Louisiana’s 3rd Annual NeauxCancer Conference

February 22, 2024 | globenewswire.com

Aspira Women's Health to Present at The Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference

February 21, 2024 | benzinga.com

First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks

February 12, 2024 | finance.yahoo.com

Aspira Women’s Health Announces Late-Breaking Poster Presentation at the Upcoming 71st Annual Scientific Meeting for the Society for Reproductive Investigation (SRI)

February 6, 2024 | finance.yahoo.com

Aspira Women’s Health Announces OvaSuite(SM) Distribution Agreement in the Philippines

January 25, 2024 | markets.businessinsider.com

Aspira Women's Health Announces $5.5 Mln Direct Offering, Private Placement; Stock Up In Pre-market

See More Headlines

Receive AWH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aspira Women's Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/10/2021
Today: 4/18/2024
Next Earnings (Estimated): 5/09/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Diagnostics & Research
Sub-Industry: N/A
Current Symbol: NASDAQ:AWH
CUSIP: N/A
CIK: 926617
Web: www.aspirawh.com
Phone: 512-519-0400
Fax: 512-439-6908
Employees: 64
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $4.45
High Stock Price Target: $5.60
Low Stock Price Target: $3.30
Potential Upside/Downside: +30.5%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($12.0050)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-16,690,000.00
Net Margins: -176.74%
Pretax Margin: -182.32%
Return on Equity: -1,099.32%
Return on Assets: -189.56%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.03
Quick Ratio: 0.99

Sales & Book Value

Annual Sales: $9.15 million
Price / Sales: 4.60
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.23) per share
Price / Book: -14.83

Miscellaneous

Outstanding Shares: 12,340,000
Free Float: 11,813,000
Market Cap: $42.08 million
Optionable: No Data
Beta: 1.61

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Dr. Torsten Hombeck Ph.D. (Age 54)
Senior VP & CFO
Comp: $374.14k
Ms. Minh Merchant (Age 51)
General Counsel & Corporate Secretary
Comp: $433.41k
Dr. Sandra Milligan J.D. (Age 60)
M.D., President
Ms. Michelle Snider
Senior Vice President of Commercial Strategy & Operations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

AWH Stock Analysis - Frequently Asked Questions

Should I buy or sell Aspira Women's Health stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aspira Women's Health in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AWH shares.
View AWH analyst ratings or view top-rated stocks.
What is Aspira Women's Health's stock price target for 2024?: 2 Wall Street analysts have issued 1 year target prices for Aspira Women's Health's shares. Their AWH share price targets range from $3.30 to $5.60. On average, they anticipate the company's share price to reach $4.45 in the next twelve months. This suggests a possible upside of 26.1% from the stock's current price.
View analysts price targets for AWH or view top-rated stocks among Wall Street analysts.
How have AWH shares performed in 2024?: Aspira Women's Health's stock was trading at $4.08 at the beginning of 2024. Since then, AWH shares have decreased by 13.5% and is now trading at $3.53.
View the best growth stocks for 2024 here.
When is Aspira Women's Health's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our AWH earnings forecast.
How were Aspira Women's Health's earnings last quarter?: Aspira Women's Health Inc. (NASDAQ:AWH) posted its earnings results on Wednesday, November, 10th. The company reported ($1.35) EPS for the quarter, missing analysts' consensus estimates of ($1.05) by $0.30. The firm earned $1.67 million during the quarter, compared to the consensus estimate of $1.50 million. Aspira Women's Health had a negative trailing twelve-month return on equity of 1,099.32% and a negative net margin of 176.74%. During the same quarter in the prior year, the company posted ($0.60) earnings per share.

When did Aspira Women's Health's stock split?: Shares of Aspira Women's Health reverse split on Friday, May 12th 2023. The 1-15 reverse split was announced on Friday, May 12th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.
What is Scott A. Carmilani's approval rating as Aspira Women's Health's CEO?: 33 employees have rated Aspira Women's Health Chief Executive Officer Scott A. Carmilani on Glassdoor.com. Scott A. Carmilani has an approval rating of 92% among the company's employees. This puts Scott A. Carmilani in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 97.0% of employees surveyed would recommend working at Aspira Women's Health to a friend.
What other stocks do shareholders of Aspira Women's Health own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Aspira Women's Health investors own include AcelRx Pharmaceuticals (ACRX), Aptinyx (APTX), Axcella Health (AXLA), Aytu BioPharma (AYTU), Calithera Biosciences (CALA), Cidara Therapeutics (CDTX), Catalyst Pharmaceuticals (CPRX), DURECT (DRRX), Geron (GERN) and
How do I buy shares of Aspira Women's Health?: Shares of AWH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AWH) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Aspira Women's Health (AWH) Stock Price, News & Analysis

Aspira Women's Health MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Aspira Women's Health Stock (NASDAQ:AWH)

AWH Stock Price History

AWH Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

AWH Stock Analysis - Frequently Asked Questions

Overall MarketRank^™